RotaTeq Solution
Tube 1
registration number
A40/30.1/0730
What RotaTeq Solution is and what it is used for
RotaTeq is an oral pentavalent vaccine indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes G1, G2, G3, G4 and G-serotypes that contain P1A[8] (e.g. G9). RotaTeq may be administered as early as 6 weeks of age.
dosage
FOR ORAL USE ONLY. NOT FOR INJECTION.
how to take
Administer dose by gently squeezing liquid into infant's mouth toward the inner cheek until dosing tube is empty. (A residual drop may remain in the tip of the tube.)
Discard the empty tube and cap in approved biological waste containers according to local regulations.
What RotaTeq Solution contains
Each 2 ml dose contains the following human-bovine rotavirus reassortants: G1, G2, G3, G4 and P1A[8]. The minimum dose levels of the reassortants are as follows:
G1 2,2 X 106 infectious units
G2 2,8 X 106 infectious units
G3 2,2 X 106 infectious units
G4 2,0 X 106 infectious units
P1A[8] 2,3 X 106 infectious units
The reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents.
other ingredients
The reassortants are suspended in a buffered stabiliser solution. Each vaccine dose contains sucrose, sodium citrate, sodium phosphate monobasic monohydrate, sodium hydroxide, polysorbate 80 and also Low Protein Kidney Medium-3 (LPKM-3) and rotavirus diluent. There are no preservatives or thimerosal present.
Contains sugar (sucrose).
Therapeutic classification
A.30.1 Biologicals - Antigens.